QUOIN-COLORED-LOGO (1).png
Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome
06 août 2024 05h00 HE | Quoin Pharmaceuticals, Inc.
Peeling Skin Syndrome is a rare autosomal disease with no approved treatment or cure Initial clinical site and pediatric patient identified in New Zealand Company actively evaluating opening...